Operator-adjusted disc-definition is successful method of glaucoma detection

Article

A recent study featured in the Journal of Glaucoma claims that operator-adjusted disc-definition is ideal for glaucoma detection when using the RTVue-100 Fourier-domain optical coherence tomograph

A recent study featured in the Journal of Glaucoma claims that operator-adjusted disc-definition is ideal for glaucoma detection when using the RTVue-100 Fourier-domain optical coherence tomograph.

An investigation led by Professor Gábor Holló et al., Semmelweis University, Hungary, evaluated the repeatability and between-method differences of optic nerve head, retinal nerve fibre layer thickness (RNFLT) measurements with the RTVue-100 Fourier-domain OCT.

All 3 disc-definition functions were used on one eye of each 126 patients. This included 72 glaucomatous, 10 ocular hypertensive and 44 healthy control eyes. To calculate measurement repeatability 33 eyes were imaged 5 times.

The findings suggested that automatic disc-definition was significantly poorer than other methods. Repeatability was matched between manual and operator-adjusted methods in all but one parameter. Refractive error, disease category or peripapillary atrophy had no effect on repeatability. Parameters measured with manual and operator-adjusted methods demonstrated high intraclass correlation (93.5% to 99.9%).

Manual and operator-adjusted disc-definition functions have similar measurement repeatability and are not influenced by refractive error, glaucoma or parapapillary atrophy. It was reported that the RTVue-100 Fourier-domain OCT method is effective in the detection of glaucoma and has high intraclass correlation.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.